{"entity":{"id":"gene-expression-signatures","kind":"term","name":"Gene-expression signatures","aka":[],"tldr":"An expression signature combines measured gene messages using a defined scoring method.","summary":"A signature combines selected RNA measurements by a defined algorithm; preprocessing, weights, reference data and software version are part of the definition; a gene list alone is not a test.","asOf":"2026-11-13","links":[{"label":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","url":"https://pubmed.ncbi.nlm.nih.gov/16199517/"},{"label":"Supervised risk predictor of breast cancer based on intrinsic subtypes.","url":"https://pubmed.ncbi.nlm.nih.gov/19204204/"},{"label":"Most random gene expression signatures are significantly associated with breast cancer outcome.","url":"https://pubmed.ncbi.nlm.nih.gov/22028643/"},{"label":"Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.","url":"https://pubmed.ncbi.nlm.nih.gov/24228635/"},{"label":"Seurat AddModuleScore definition","url":"https://satijalab.org/seurat/reference/addmodulescore"}],"tags":[],"related":["bulk-rna-seq"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["A signature combines selected RNA measurements by a defined algorithm; preprocessing, weights, reference data and software version are part of the definition; a gene list alone is not a test.","Pattern or module score, subtype classifier and outcome predictor answer different questions; performance belongs to a population, endpoint and horizon.","The original PAM50 work used a defined 50-gene method for intrinsic subtypes and risk models and does not validate every later similar score.","Seurat's AddModuleScore subtracts matched control-gene expression from the selected-gene mean; GSEA tests accumulation toward one end of a ranked list; outputs cannot share a cutoff.","A clinical predictor needs a locked procedure; in the Venet et al. (2011) breast-cancer analysis, more than 90% of random signatures over 100 genes were significant outcome predictors, so association alone does not show the named biology matters.","Analytical repeatability, clinical validity and clinical utility are separate questions.","A bulk inflammatory signature can rise from more immune cells, changed state or both; a stress score does not establish protein activation, metabolic rate or dependence.","Fictional teaching exercise: Replacing normalisation while retaining the old high cutoff is not validated; the old cutoff cannot supply missing validation.","An expression score requires compatible RNA input, locked preprocessing, genes, weights, reference, endpoint/horizon and software version. Existing data can be rescored without new tissue; acquiring RNA consumes material. Report categories, ranks, probabilities or unitless scores on their exact scale. Missing genes, batch, mixture and population shift undermine cutoffs; analytical, clinical and utility evidence remain separate.","An expression-program score has meaning within its algorithm and background. For a score formed by subtracting matched control-gene expression, zero need not mean that no program genes were detected. The 90th percentile places a result relative to a specified reference; it does not mean that 90 percent of cells express the program or that a pathway is 90 percent active. Changing the genes, preprocessing, controls or reference can change the scale, so retain them with the method and version."],"category":"Genomics & genetics"},"route":"/terms/gene-expression-signatures/","neighbours":{"term":[{"id":"bulk-rna-seq","kind":"term","name":"Bulk RNA sequencing (RNA-seq) and the full transcriptome","route":"/terms/bulk-rna-seq/"}]}}